SLS
#1856
SELLAS Life Sciences Group, Inc. - Common Stock
13.3 9 USD
+0.06%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+6.10%
Changement Mensuel
+76.18%
Evolution sur 6 mois
+258.98%
Changement Annuel
+597.40%
Clôture Précédente
12.6 2
Open
13.3 9
Low
13.3 9
High
13.3 9
Volume
102
Financials
- Market Capitalization 2.49 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1837 |  IMNM Immunome, Inc. - Common Stock | 22.59 USD | -0.92% | -6.54% | +25.29% | +163.59% | 2.56 B USD | ||
| 1845 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.91 USD | +8.41% | -8.15% | +22.09% | +161.08% | 2.54 B USD | ||
| 1860 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.74 USD | -1.72% | -11.05% | +7.15% | +11.31% | 2.48 B USD | ||
| 1873 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 56.11 USD | -5.40% | -20.06% | -9.69% | -15.06% | 2.41 B USD |